WuXi AppTec Co., Ltd. (HKG:2359)

Market Cap	283.80B
Revenue (ttm)	45.45B
Net Income (ttm)	15.09B
Shares Out	n/a
EPS (ttm)	4.39
PE Ratio	18.81
Forward PE	18.77
Dividend	1.43 (1.44%)
Ex-Dividend Date	May 15, 2025

Volume	7,001,045
Average Volume	12,843,675
Open	97.95
Previous Close	100.10
Day's Range	97.15 - 101.10
52-Week Range	30.60 - 116.50
Beta	0.73
RSI	58.56
Earnings Date	Jul 27, 2025

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug development from discovery to commercial covering various categories for various synthetic molecula...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2000
• Employees: 39,414
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2359

Financial Performance

In 2024, WuXi AppTec's revenue was 37.92 billion, a decrease of -1.97% compared to the previous year's 38.68 billion. Earnings were 9.45 billion, a decrease of -1.63%.

Financial numbers in CNY